Review Article
The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty
Table 1
Description of RECORD trials comparing rivaroxaban to enoxaparin for VTE prophylaxis in patients undergoing THA and TKA.
| Procedure | RECORD 1 | RECORD 2 | RECORD 3 | RECORD 4 | THA | THA | TKA | TKA |
| Rivaroxaban dose | 10 mg daily | 10 mg daily | 10 mg daily | 10 mg daily | Enoxaparin dose | 40 mg daily | 40 mg daily | 40 mg daily | 30 mg BID | Treatment duration (days) | 31–39 | Enoxaparin 10–14, rivaroxaban 31–39 | 10–14 | 10–14
| Patients () | 4541 | 2509 | 2531 | 3148 |
|
|